Jentes ES, Han P, Gershman MD, Rao SR, LaRocque RC, Staples JE, Ryan ET, and the Global TravEpiNet ConsortiumTravel Characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011 Am J Trop Med Hyg. 2013; 88(5):954-961

Davis XM, Hay KA, Plier DA, Chaves SS, Lim PL, Caumes E, Castelli F, Kozarsky PE, Cetron MS, Freedman DO; GeoSentinel Surveillance NetworkInternational travelers as sentinels for sustained influenza transmission during the 2009 influenza A(H1N1)pdm09 pandemic. J Travel Med. 2013 May-Jun;20(3):177-84. doi: 10.1111/jtm.12025. Epub 2013 Mar 14

Schwartz E, Connor BA. Typhoid Infection. British Medical Journal Point of Care 201

Boggild AK, Castelli F, Gautret P, Torresi J, von Sonnenburg F, Barnett ED, Greenaway CA, Lim PL, Schwartz E, Wilder-Smith A, Wilson ME; GeoSentinel Surveillance NetworkVaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network.Vaccine. 2010 Oct 28;28(46):7389-95. doi: 10.1016/j.vaccine.2010.09.009. Epub 2010 Sep 17.

Burchard GD, Caumes E, Connor BA, Freedman DO, Jelinek T, Jong EC, von Sonnenburg F, Steffen R, Tsai TF, Wilder-Smith A, Zuckerman J. Expert Opinion on Vaccination of Travelers Against Japanese Encephalitis J Trav Med 2009; 16 (3): 204–216

Connor BA, Schwartz E. Typhoid fever: the temporal relations of key clinical diagnostic points – Reply. Lancet Infect Dis 2006; 6(6):320-321

Connor BA, Schwartz E. Typhoid and paratyphoid fever in travelers. Lancet Infect Dis 2005; 5: 623-628

Martin M, Weld L, Tsai T and the GeoSentinel Yellow Fever Working GroupAdvanced age a risk factor for illness temporally associated with Yellow Fever vaccination. Emerg Infect Dis, 2001 7(6):945-951

Connor BA, Shlim DR, Taylor DN. Prevention of Japanese encephalitis infection in travelers (monograph). Connaught Laboratories, 1994.